CD8A and COVID-19: In addition, as our acquaintance with this novel CoV continues, we will be able to determine whether there is long-term survival (at least at >1 y) of SARS-CoV-2−specific CD8+ memory T cells following primary COVID-19 along with whether, in now healthy survivors, they can be activated and clonally expanded following challenge with an appropriate vaccine.